Pricing Log in Create free account

Evaxion A/S - Sponsored ADR (EVAX) vs IGC Pharma, Inc. (IGC)

Evaxion A/S - Sponsored ADR and IGC Pharma, Inc. are both Biotechnology companies. Evaxion A/S - Sponsored ADR and IGC Pharma, Inc. are of similar size ($23.0M and $22.0M). Evaxion A/S - Sponsored ADR has the higher net margin (0.00% vs −836.1%) and the lower return on invested capital (−245.8% vs −90.5%). Across the 16 metrics below, Evaxion A/S - Sponsored ADR leads on 12 and IGC Pharma, Inc. on 4.

Valuation

Metric EVAX IGC Biotechnology median
P/E n/m n/m 10.60
P/S 2.06 18.89 9.40
P/B 2.31 3.20 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.38 19.31 9.02
Earnings yield (32.88%) (47.37%) (32.88%)
Free cash flow yield (139.47%) (27.39%) (23.13%)

Profitability

Metric EVAX IGC Biotechnology median
Gross margin 100.00% 23.89% 68.51%
Operating margin 0.00% (914.80%) 0.00%
Net margin 0.00% (836.06%) 0.00%
Free cash flow margin 0.00% (485.92%) 0.00%
Return on equity (96.10%) (126.16%) (51.96%)
Return on assets (36.20%) (94.55%) (46.06%)
Return on invested capital (245.79%) (90.48%) 0.00%

Growth

Metric EVAX IGC Biotechnology median
Revenue growth (TTM) — (17.03%) 6.76%
EPS growth (last fiscal year) 87.79% 57.85% 29.88%
Revenue growth, 5-year CAGR — (20.77%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EVAX IGC Biotechnology median
Debt to equity 0.71 0.13 0.00
Current ratio 5.06 0.42 4.97
Net debt to EBITDA 1.87 0.04 1.01

Dividend

Metric EVAX IGC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EVAX IGC Biotechnology median
Market cap 23.02m 21.95m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack